Aarti Pharmalabs Limited (AARTIPHARM) — Cash Flow Quality Index
Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Quality Index of 0.71x as of December 2023. Operating cash flow of Rs375.40 Million is below net income of Rs527.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Aarti Pharmalabs Limited (AARTIPHARM) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aarti Pharmalabs Limited Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Aarti Pharmalabs Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AARTIPHARM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Aarti Pharmalabs Limited (2022–2025)
Year-by-year earnings quality comparison for Aarti Pharmalabs Limited. For live market cap and the full company financial profile, see market cap of Aarti Pharmalabs Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | Rs3.32 Billion | Rs2.72 Billion | ▲ +22.0% |
| 2024 | 1.00x | Rs2.16 Billion | Rs2.17 Billion | ▼ -1.1% |
| 2023 | 1.01x | Rs2.63 Billion | Rs2.61 Billion | ▲ +458.6% |
| 2022 | -0.28x | Rs-437.04 Million | Rs1.55 Billion | — |